Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from 4DMedical Ltd ( (AU:4DX) ).
4DMedical Limited has issued 339,255 fully paid ordinary shares following the exercise of options under its Long Term Incentive Plan. This issuance was completed without disclosure to investors under specific provisions of the Corporations Act, and the company has ensured compliance with relevant legislative requirements, indicating a strategic move to strengthen its financial position and incentivize long-term growth.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$1.05 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited operates in the healthcare industry, focusing on innovative medical imaging solutions, particularly for lung health. The company is known for its advanced imaging technology that enhances the diagnosis and treatment of respiratory conditions, aiming to improve patient outcomes and healthcare efficiency.
Average Trading Volume: 3,993,419
Technical Sentiment Signal: Buy
Current Market Cap: A$724.4M
See more data about 4DX stock on TipRanks’ Stock Analysis page.